Literature DB >> 14757835

A novel concept for ligand attachment to oligonucleotides via a 2'-succinyl linker.

Johannes Winkler1, Ernst Urban, Doris Losert, Volker Wacheck, Hubert Pehamberger, Christian R Noe.   

Abstract

Conjugation of ligands to antisense oligonucleotides is a promising approach for enhancing their effects. In this report, a new method for synthesizing oligonucleotide conjugates is described. 2'-Amino-2'-deoxy-5'-dimethoxytrityl-uridine was select ively acylated with a succinic acid linker at the 2' position. This compound was incorporated at the 3' end of an oligonucleotide corresponding to the sequence of Oblimersen. The carboxyl group was protected for oligonucleotide synthesis as a benzyl ester, which could be selectively cleaved at the solid phase by a catalytic phase transfer reaction using palladium nanoparticles as catalyst. An oligonucleotide-fluorescein conjugate was prepared by condensation of aminofluorescein. Circular dichroism spectroscopic experiments showed a B-DNA type structure. The melting temperature of the duplex was only slightly lower than that of Oblimersen. Biological activity measured by western blotting resulted in a Bcl-2 target downregulation nearly identical to that of control Oblimersen on human melanoma cells, proving that this method is attractive for the binding of ligands located in the minor groove.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14757835      PMCID: PMC373351          DOI: 10.1093/nar/gkh229

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  20 in total

1.  2'-Amino-2'-deoxyuridine via an Intramolecular Cyclization of a Trichloroacetimidate.

Authors:  Danny P. C. McGee; Alecia Vaughn-Settle; Chandra Vargeese; Yansheng Zhai
Journal:  J Org Chem       Date:  1996-01-26       Impact factor: 4.354

2.  Chemosensitisation of malignant melanoma by BCL2 antisense therapy.

Authors:  B Jansen; V Wacheck; E Heere-Ress; H Schlagbauer-Wadl; C Hoeller; T Lucas; M Hoermann; U Hollenstein; K Wolff; H Pehamberger
Journal:  Lancet       Date:  2000-11-18       Impact factor: 79.321

3.  bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice.

Authors:  B Jansen; H Schlagbauer-Wadl; B D Brown; R N Bryan; A van Elsas; M Müller; K Wolff; H G Eichler; H Pehamberger
Journal:  Nat Med       Date:  1998-02       Impact factor: 53.440

Review 4.  2'-carbohydrate modifications in antisense oligonucleotide therapy: importance of conformation, configuration and conjugation.

Authors:  M Manoharan
Journal:  Biochim Biophys Acta       Date:  1999-12-10

5.  Transfer hydrogenation; a convenient method for removal of some commonly used protecting groups in peptide synthesis.

Authors:  G M Anantharamaiah; K M Sivanandaiah
Journal:  J Chem Soc Perkin 1       Date:  1977

6.  Palladium(0)-catalyzed coupling-cyclization reaction of polymer-supported aryl iodides with 1,2-allenyl carboxylic acids. Solid-phase parallel synthesis of butenolides.

Authors:  Shengming Ma; Dehui Duan; Yizhong Wang
Journal:  J Comb Chem       Date:  2002 May-Jun

7.  Matrix-assisted laser desorption ionization time-of-flight mass spectrometry: a powerful tool for the mass and sequence analysis of natural and modified oligonucleotides.

Authors:  U Pieles; W Zürcher; M Schär; H E Moser
Journal:  Nucleic Acids Res       Date:  1993-07-11       Impact factor: 16.971

8.  Synthesis of 2'-modified oligodeoxynucleotides via on-column conjugation.

Authors:  J T Hwang; M M Greenberg
Journal:  J Org Chem       Date:  2001-01-26       Impact factor: 4.354

9.  Preparation and evaluation of tumor-targeting peptide-oligonucleotide conjugates.

Authors:  W Mier; R Eritja; A Mohammed; U Haberkorn; M Eisenhut
Journal:  Bioconjug Chem       Date:  2000 Nov-Dec       Impact factor: 4.774

Review 10.  Potential roles of antisense oligonucleotides in cancer therapy. The example of Bcl-2 antisense oligonucleotides.

Authors:  Nathalie Dias; C A Stein
Journal:  Eur J Pharm Biopharm       Date:  2002-11       Impact factor: 5.571

View more
  3 in total

1.  Synthesis of functionalised nucleosides for incorporation into nucleic acid-based serine protease mimics.

Authors:  Mieke A Catry; Annemieke Madder
Journal:  Molecules       Date:  2007-01-31       Impact factor: 4.411

2.  Fluorogenic affinity label for the facile, rapid imaging of proteins in live cells.

Authors:  Rex W Watkins; Luke D Lavis; Vanessa M Kung; Georgyi V Los; Ronald T Raines
Journal:  Org Biomol Chem       Date:  2009-07-31       Impact factor: 3.876

Review 3.  Oligonucleotide conjugates for therapeutic applications.

Authors:  Johannes Winkler
Journal:  Ther Deliv       Date:  2013-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.